• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型双(吖啶-4-甲酰胺)类抗癌剂的设计、合成及生物学特性

Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.

作者信息

Antonini Ippolito, Polucci Paolo, Magnano Amelia, Gatto Barbara, Palumbo Manlio, Menta Ernesto, Pescalli Nicoletta, Martelli Sante

机构信息

Department of Chemical Sciences, University of Camerino, Via S Agostino 1, 62032 Camerino, Italy.

出版信息

J Med Chem. 2003 Jul 3;46(14):3109-15. doi: 10.1021/jm030820x.

DOI:10.1021/jm030820x
PMID:12825949
Abstract

To enhance the outstanding biological response shown by the corresponding monomers 4 and 5, two classes of bis-acridine-4-carboxamides, 9, with a linker between the 4,4' positions, and 13, with a linker between the 1,1' positions, have been prepared as DNA-binding and potential antitumor agents. The noncovalent DNA-binding properties of these compounds have been examined using gel-electrophoresis and fluorometric techniques. The results indicate that (i). target compounds intercalate DNA; (ii). the bis derivatives with the optimal linker are considerably more DNA-affinic than corresponding monomers; (iii). overall affinity is sensitive to the nature of the linker, of the chromophores, and of the substituents at 7,7'; (iv). often, the bis derivatives show a marked AT-preferential binding. In vitro cytotoxic potency of these derivatives toward the human colon adenocarcinoma cell line (HT29) is described and compared to that of reference drugs. Structure-activity relationships are discussed. Some highly DNA-affinic and potent cytotoxic compounds, 9b,f and 13b,c, have been selected for the National Cancer Institute (NCI) screening on 60 human tumor cell lines and identified as new leads in the antitumor strategies.

摘要

为了增强相应单体4和5所表现出的出色生物响应,已制备了两类双吖啶-4-羧酰胺,即在4,4'位之间带有连接基的9和在1,1'位之间带有连接基的13,作为DNA结合剂和潜在的抗肿瘤剂。已使用凝胶电泳和荧光技术研究了这些化合物的非共价DNA结合特性。结果表明:(i). 目标化合物可插入DNA;(ii). 带有最佳连接基的双衍生物对DNA的亲和力远高于相应的单体;(iii). 总体亲和力对连接基、发色团以及7,7'位取代基的性质敏感;(iv). 双衍生物通常表现出明显的AT优先结合。描述了这些衍生物对人结肠腺癌细胞系(HT29)的体外细胞毒性效力,并与参考药物进行了比较。讨论了构效关系。已选择一些具有高度DNA亲和力和强效细胞毒性的化合物9b、f和13b、c,用于美国国立癌症研究所(NCI)对60种人类肿瘤细胞系的筛选,并被确定为抗肿瘤策略中的新先导物。

相似文献

1
Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.新型双(吖啶-4-甲酰胺)类抗癌剂的设计、合成及生物学特性
J Med Chem. 2003 Jul 3;46(14):3109-15. doi: 10.1021/jm030820x.
2
Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.新型抗癌剂双(嘧啶并[5,6,1 - de]吖啶)和双(吡唑并[3,4,5 - kl]吖啶 - 5 - 甲酰胺)的合理设计、合成及生物学评价
J Med Chem. 2004 Oct 7;47(21):5244-50. doi: 10.1021/jm049706k.
3
Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.取代双(吖啶-4-甲酰胺)的构效关系:一类新型抗癌剂。
J Med Chem. 1999 Jul 1;42(13):2383-93. doi: 10.1021/jm980687m.
4
2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.2,3-二氢-1H,7H-嘧啶并[5,6,1-de]吖啶-1,3,7-三酮衍生物,一类对多药耐药细胞系有活性的细胞毒性剂:合成、生物学评价及构效关系
J Med Chem. 1999 Jul 15;42(14):2535-41. doi: 10.1021/jm9805586.
5
1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.作为嵌入型细胞毒性剂的1-[(ω-氨基烷基)氨基]-4-[N-(ω-氨基烷基)氨基甲酰基]-9-氧代-9,10-二氢吖啶:合成、DNA结合及生物学评价
J Med Chem. 1997 Nov 7;40(23):3749-55. doi: 10.1021/jm970114u.
6
4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.4-羟甲基-3-氨基吖啶衍生物作为一类新型抗癌剂
J Med Chem. 2003 Mar 13;46(6):967-77. doi: 10.1021/jm020389w.
7
2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.2,6-二(ω-氨基烷基)-2,5,6,7-四氢吡唑并[3,4,5-mn]嘧啶并[5,6,1-de]吖啶-5,7-二酮:新型、强效、具有细胞毒性且能与DNA结合的试剂。
J Med Chem. 2002 Jan 31;45(3):696-702. doi: 10.1021/jm011004x.
8
Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.抗肿瘤剂。3. 具有强细胞毒性活性的新型吡啶并异喹啉二酮和二氢噻吩并喹啉二酮衍生物的设计、合成及生物学评价。
J Med Chem. 2004 Feb 12;47(4):849-58. doi: 10.1021/jm030918b.
9
Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.新型N-5,2-二(ω-氨基烷基)-2,6-二氢吡唑并[3,4,5-kl]吖啶-5-甲酰胺的合成、抗肿瘤细胞毒性及与DNA的结合
J Med Chem. 2001 Sep 27;44(20):3329-33. doi: 10.1021/jm010917o.
10
Bisintercalating threading diacridines: relationships between DNA binding, cytotoxicity, and cell cycle arrest.双嵌入穿线二吖啶:DNA 结合、细胞毒性与细胞周期阻滞之间的关系
J Med Chem. 2003 Dec 18;46(26):5790-802. doi: 10.1021/jm030253d.

引用本文的文献

1
Synthesis and Evaluation of Novel Bis-Chalcone Derivatives Containing a Thiophene Moiety as Potential Anticancer Agents: In Vitro, In Silico , and Mechanistic Studies.含噻吩部分的新型双查耳酮衍生物作为潜在抗癌剂的合成与评价:体外、计算机模拟及机制研究
ACS Omega. 2025 Jun 10;10(24):25921-25937. doi: 10.1021/acsomega.5c02394. eCollection 2025 Jun 24.
2
Synthesis, and antibacterial activities of novel 1,3,4a,9-tetraza-4H-fluoren-2-amines incorporating phenoxy-N-arylacetamide, pyrazole, and 2-(4-(1-phenyl-1H-pyrazol-3-yl)phenoxy)-N-arylacetamide moieties.新型1,3,4a,9-四氮杂-4H-芴-2-胺的合成及其抗菌活性,该新型胺类化合物包含苯氧基-N-芳基乙酰胺、吡唑和2-(4-(1-苯基-1H-吡唑-3-基)苯氧基)-N-芳基乙酰胺部分。
BMC Chem. 2025 Mar 8;19(1):61. doi: 10.1186/s13065-025-01421-5.
3
Boron Trifluoride Etherate Promoted Microwave-Assisted Synthesis of Antimalarial Acridones.三氟化硼乙醚络合物促进的微波辅助合成抗疟吖啶酮
RSC Adv. 2019;9(72):42284-42293. doi: 10.1039/c9ra09478d. Epub 2019 Dec 20.
4
What Can Electrochemical Methods Offer in Determining DNA-Drug Interactions?电化学方法在测定 DNA-药物相互作用方面有何作用?
Molecules. 2021 Jun 7;26(11):3478. doi: 10.3390/molecules26113478.
5
Intercalating Electron Dyes for TEM Visualization of DNA at the Single-Molecule Level.用于单分子水平 TEM 可视化 DNA 的插入式电子染料。
Chembiochem. 2019 Mar 15;20(6):822-830. doi: 10.1002/cbic.201800638. Epub 2019 Feb 7.
6
Medicinal chemistry of acridine and its analogues.吖啶及其类似物的药物化学
Medchemcomm. 2018 Aug 14;9(10):1589-1618. doi: 10.1039/c8md00384j. eCollection 2018 Oct 1.
7
Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.开发针对 CUG 三核苷酸重复序列的双价配体,该序列是 1 型肌强直性营养不良的致病因子。
J Med Chem. 2013 Dec 12;56(23):9471-9481. doi: 10.1021/jm400794z. Epub 2013 Nov 21.
8
Synthesis of acridines by the [4 + 2] annulation of arynes and 2-aminoaryl ketones.通过芳炔与 2-氨基芳基酮的[4 + 2]环加成反应合成吖啶。
J Org Chem. 2010 Apr 2;75(7):2289-95. doi: 10.1021/jo1000687.
9
New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.旧药新希望:重新审视作为抗癌药物的 DNA 结合小分子。
Future Oncol. 2009 Dec;5(10):1685-704. doi: 10.2217/fon.09.127.
10
Dimeric approaches to anti-cancer chemotherapeutics.抗癌化疗药物的二聚体方法。
Anticancer Agents Med Chem. 2008 Oct;8(7):807-16. doi: 10.2174/187152008785914743.